| Name | Title | Contact Details |
|---|
Autonomous Solutions, Inc. (ASI) is a leader in industrial vehicle automation, focusing on retrofitting existing equipment with autonomous technology. Founded in 2000 and based in Petersboro, Utah, ASI operates a 100-acre proving ground for robotics testing. The company provides OEM/vendor-independent automation solutions for various sectors, employing between 201 and 500 staff and serving clients across six continents. ASI offers a range of products and services, including the Mobius® Fleet Management System for coordinating autonomous fleets and custom automation kits for vehicles of all sizes. Their solutions cater to multiple industries, such as mining, automotive, agriculture, military, construction, logistics, security, and research. Notable clients include Ford Motor Company, Anglo American, John Deere, and the U.S. Department of Defense. ASI emphasizes all-weather, 24/7 operation, enhancing efficiency and reducing costs in applications like landscaping.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
27North Inc. is a luxury expedition vehicle manufacturer, providing durable and luxurious vehicles tailored to suit adventure seekers, leisurely travelers, and mobile lifestyle enthusiasts. Since 2017, our team has provided our clients with the highest quality, first-class service. With our comprehensive offerings, you can expect to receive superior customer service from the initial contact and beyond.
The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 48,000 employees around the world, the company contributes to sustainable society by providing solutions to the worlds challenges through its three business sectors of Material, Homes, and Health Care.